These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3936628)

  • 1. Simultaneous determination of 2-mercaptoethanesulfonate and its disulfide in human urine by isotachophoresis.
    Ikeuchi I; Amano T
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):3016-9. PubMed ID: 3936628
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency.
    Duran M; Aarsen G; Fokkens RH; Nibbering NM; Cats BP; de Bree PK; Wadman SK
    Clin Chim Acta; 1981 Mar; 111(1):47-53. PubMed ID: 6784974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection.
    James CA; Rogers HJ
    J Chromatogr; 1986 Oct; 382():394-8. PubMed ID: 3097045
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of coenzyme m (2-mercaptoethanesulfonic acid) derivatives by isotachophoresis.
    Hermans JM; Hutten TJ; van der Drift C; Vogels GD
    Anal Biochem; 1980 Aug; 106(2):363-6. PubMed ID: 6778250
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion of disodium bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosing.
    Shaw IC; Weeks MS
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):933-5. PubMed ID: 3117563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of [14C]-mesna in the rat.
    Shaw IC; Graham MI; Jones MS
    Arzneimittelforschung; 1986 Mar; 36(3):487-9. PubMed ID: 3085684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive ketone tests: a bedside measure of urinary mesna.
    Goren MP; Pratt CB
    Cancer Chemother Pharmacol; 1990; 25(5):371-2. PubMed ID: 2106398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing.
    Jones MS; Murrell RD; Shaw IC
    Eur J Cancer Clin Oncol; 1985 May; 21(5):553-5. PubMed ID: 3924627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.
    Reuther H; Kohl M; Wildenauer DB
    Arzneimittelforschung; 1986 Apr; 36(4):763-5. PubMed ID: 3087373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesna excretion and ifosfamide nephrotoxicity in children.
    Goren MP; Pratt CB; Meyer WH; Wright RK; Dodge RK; Viar MJ
    Cancer Res; 1989 Dec; 49(24 Pt 1):7153-7. PubMed ID: 2510931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesna--a short review.
    Shaw IC; Graham MI
    Cancer Treat Rev; 1987 Jun; 14(2):67-86. PubMed ID: 3119211
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N; Stekar J
    Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of sodium 2-mercaptoethanesulphonate by high-performance liquid chromatography using post-column reaction colorimetry or electrochemical detection.
    Sidau B; Shaw IC
    J Chromatogr; 1984 Nov; 311(1):234-8. PubMed ID: 6440899
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N; Pohl J
    IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of sodium 2-mercaptoethanesulfonate (MESNA) and its metabolite, disulfide form (DIMESNA), in volunteers after oral dosing: a comparison between MESNA and ARGIMESNA.
    Pea F; Mazzo M; Miglioli PA; Casiglia E; Pessina A; Moretti V
    Pharmacol Res; 1992; 25 Suppl 1():85-6. PubMed ID: 1508821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration].
    Roth B; Cerny T; Brunner KW; Küpfer A
    Schweiz Med Wochenschr; 1989 Aug; 119(34):1153-8. PubMed ID: 2510294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatography of some coenzyme M (2-mercaptoethanesulphonic acid) derivatives by ion pairing on reversed-phase columns.
    Apostolides Z; Vermeulen NM; Potgieter DJ
    J Chromatogr; 1982 Sep; 246(2):304-7. PubMed ID: 6815216
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.
    Ormstad K; Orrenius S; Låstbom T; Uehara N; Pohl J; Stekar J; Brock N
    Cancer Res; 1983 Jan; 43(1):333-8. PubMed ID: 6401168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of Prehepon (sodium 2-mercaptoethanesulfonate) on reproduction in rats].
    Stĕtinová V; Grossmann V
    Cesk Farm; 1988 Dec; 37(10):450-2. PubMed ID: 3149913
    [No Abstract]   [Full Text] [Related]  

  • 20. Causes, consequences, and recognition of false-positive reactions for ketones.
    Csako G
    Clin Chem; 1990 Jul; 36(7):1388-9. PubMed ID: 2115414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.